デフォルト表紙
市場調査レポート
商品コード
1356769

女性不妊症診断・治療市場レポート:2030年までの動向、予測、競合分析

Female Infertility Diagnosis and Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030


出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

女性不妊症診断・治療市場レポート:2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

女性不妊症診断・治療の動向と予測

世界の女性不妊症診断・治療市場は、2024年から2030年までのCAGRが7.7%で、2030年までに推定20億米ドルに達すると予測されます。この市場の主な促進要因は、ダウン症、ONTD、その他の疾患などの遺伝性疾患の有病率の増加、回避可能な治療に対する意識の高まり、生殖補助医療技術の技術的進歩です。世界の女性不妊症診断・治療市場の将来は、病院・クリニック、在宅医療、病理・診断センターの各市場におけるビジネスチャンスによって有望視されています。

女性不妊症診断・治療市場の洞察

Lucintelの予測では、生殖補助医療技術は、体外受精(IVF)、人工授精(AI-IUI)、凍結胚移植(FET)など、女性の不妊症治療のための継続的な技術進歩により、予測期間中に最も高い成長が見込まれています。

この市場の中で、病院・クリニックは、大規模な顧客基盤の存在と、医師による新しい技術的先進実践の採用の増加により、最大のセグメントであり続けると思われます。

アジア太平洋地域は、不妊症関連の問題の蔓延と医療への支出の増加により、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるのか?
  • Q.1.1.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか?

目次

第1章 エグゼクティブサマリー

第2章 世界の女性不妊症診断・治療市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界の女性不妊症診断・治療市場動向(2018~2023年)と予測(2024~2030年)
  • 治療別の世界の女性不妊症診断・治療市場
    • 薬剤
    • 手術
    • 子宮内授精
    • 生殖補助医療
  • 診断別の世界の女性不妊症診断・治療市場
    • 排卵検査
    • 子宮卵管造影
    • 子宮鏡検査
    • 画像検査
    • 卵巣予備能検査
    • ホルモンレベル検査
    • 遺伝子検査
    • その他
  • 最終用途別の世界の女性不妊症診断・治療市場
    • 病院・クリニック
    • 在宅医療
    • 病理・診断センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の女性不妊症診断・治療市場
  • 北米の女性不妊症診断・治療市場
  • 欧州の女性不妊症診断・治療市場
  • アジア太平洋地域の女性不妊症診断・治療市場
  • その他地域の女性不妊症診断・治療市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 治療別の世界の女性不妊症診断・治療市場の成長機会
    • 診断別の世界の女性不妊症診断・治療市場の成長機会
    • 最終用途別の世界の女性不妊症診断・治療市場の成長機会
    • 地域別の世界の女性不妊症診断・治療市場の成長機会
  • 世界の女性不妊症診断・治療市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の女性不妊症診断・治療市場の能力拡大
    • 世界の女性不妊症診断・治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Bayer AG
  • Church & Dwight
  • Genea
  • Pfizer
  • Vitrolife Sweden AB
  • Esco Group
  • Fairhaven Health
  • Ferring B.V.
目次

Female Infertility Diagnosis and Treatment Trends and Forecast

The future of the global female infertility diagnosis and treatment market looks promising with opportunities in the hospitals & clinic, homecare, and pathology & diagnostic centers markets. The global female infertility diagnosis and treatment market is expected to reach an estimated $2.0 billion by 2030 with a CAGR of 7.7% from 2024 to 2030. The major drivers for this market are growing prevalence of genetic disorders, such as Down syndrome, ONTD, and other disorders, increasing awareness towards avialable treatment, and technological advancement of assisted reproductive technology.

A more than 150-page report is developed to help in your business decisions.

Female Infertility Diagnosis and Treatment by Segment

The study includes a forecast for the global female infertility diagnosis and treatment by treatment, diagnosis, end use, and region.

Female Infertility Diagnosis and Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Drugs
  • Surgery
  • Intrauterine Insemination
  • Assisted Reproductive Technology

Female Infertility Diagnosis and Treatment Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Ovulation Testing
  • Hysterosalpingography
  • Hysteroscopy
  • Imaging Testing
  • Ovarian Reserve Testing
  • Hormonal Level Testing
  • Genetic Testing
  • Others

Female Infertility Diagnosis and Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Homecare
  • Pathology and Diagnostic Centers
  • Others

Female Infertility Diagnosis and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Female Infertility Diagnosis and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies female infertility diagnosis and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the female infertility diagnosis and treatment companies profiled in this report include-

  • Bayer Ag
  • Church & Dwight
  • Genea
  • Pfizer
  • Vitrolife Sweden Ab
  • Esco Group
  • Fairhaven Health
  • Ferring B.V.

Female Infertility Diagnosis and Treatment Market Insights

Lucintel forecasts that assisted reproductive technology is expected to witness highest growth over the forecast period due to on-going technological advancements, which includes in vitro fertilization (IVF), artificial insemination(AI-IUI), and frozen embryo transfer(FET for treating infertility in women.

Within this market, hospitals and clinics will remain the largest segment due to presence of large customer base and growing adoption of new technologically advanced practices by doctors.

Asia Pacific is expected to witness highest growth over the forecast period due to prevalence of infertility-related issues and increasing expenditure on healthcare in the region.

Features of the Global Female Infertility Diagnosis and Treatment Market

Market Size Estimates: Female infertility diagnosis and treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Female infertility diagnosis and treatment market size by treatment, diagnosis, end use, and region. in terms of value ($B).

Regional Analysis: Female infertility diagnosis and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatments, diagnosis, end uses, and region.s for the female infertility diagnosis and treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the female infertility diagnosis and treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the female infertility diagnosis and treatment market size?

Answer: The global female infertility diagnosis and treatment market is expected to reach an estimated $2.0 billion by 2030.

Q.2. What is the growth forecast for female infertility diagnosis and treatment market?

Answer: The global female infertility diagnosis and treatment market is expected to grow with a CAGR of 7.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the female infertility diagnosis and treatment market?

Answer: The major drivers for this market are growing prevalence of genetic disorders, such as Down syndrome, ONTD, and other disorders, increasing awareness towards avialable treatment, and technological advancement of assisted reproductive technology.

Q.4. What are the major segments for female infertility diagnosis and treatment market?

Answer: The future of the female infertility diagnosis and treatment market looks promising with opportunities in the hospitals & clinic, homecare, and pathology & diagnostic centers markets.

Q.5. Who are the key female infertility diagnosis and treatment market companies?

Answer: Some of the key female infertility diagnosis and treatment companies are as follows:

  • Bayer AG
  • Church & Dwight
  • Genea
  • Pfizer
  • Vitrolife Sweden AB
  • Esco Group
  • Fairhaven Health
  • Ferring B.V.

Q.6. Which female infertility diagnosis and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that assisted reproductive technology is expected to witness highest growth over the forecast period due to on-going technological advancements, which includes in vitro fertilization (IVF), artificial insemination(AI-IUI), and frozen embryo transfer(FET for treating infertility in women.

Q.7. In female infertility diagnosis and treatment market, which region is expected to be the largest in next 5 years?

Answer: Asia Pacific is expected to witness highest growth over the forecast period due to prevalence of infertility-related issues and increasing expenditure on healthcare in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the female infertility diagnosis and treatment market by treatment (drugs, surgery, intrauterine insemination, and assisted reproductive technology), diagnosis (ovulation testing, hysterosalpingography, hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others), end use (hospitals & clinics, homecare, pathology & diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.1. 1. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Female Infertility Diagnosis and Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Female Infertility Diagnosis and Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Female Infertility Diagnosis and Treatment Market by Treatment
    • 3.3.1: Drugs
    • 3.3.2: Surgery
    • 3.3.3: Intrauterine Insemination
    • 3.3.4: Assisted Reproductive Technology
  • 3.4: Global Female Infertility Diagnosis and Treatment Market by Diagnosis
    • 3.4.1: Ovulation Testing
    • 3.4.2: Hysterosalpingography
    • 3.4.3: Hysteroscopy
    • 3.4.4: Imaging Testing
    • 3.4.5: Ovarian Reserve Testing
    • 3.4.6: Hormonal Level Testing
    • 3.4.7: Genetic Testing
    • 3.4.8: Others
  • 3.5: Global Female Infertility Diagnosis and Treatment Market by End Use
    • 3.5.1: Hospitals and Clinics
    • 3.5.2: Homecare
    • 3.5.3: Pathology and Diagnostic Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Female Infertility Diagnosis and Treatment Market by Region
  • 4.2: North American Female Infertility Diagnosis and Treatment Market
    • 4.2.2: North American Female Infertility Diagnosis and Treatment Market by End Use: Hospitals and Clinics, Homecare, Pathology and Diagnostic Centers, and Others
  • 4.3: European Female Infertility Diagnosis and Treatment Market
    • 4.3.1: European Female Infertility Diagnosis and Treatment Market by Treatment: Drugs, Surgery, Intrauterine Insemination, and Assisted Reproductive Technology
    • 4.3.2: European Female Infertility Diagnosis and Treatment Market by End Use: Hospitals and Clinics, Homecare, Pathology and Diagnostic Centers, and Others
  • 4.4: APAC Female Infertility Diagnosis and Treatment Market
    • 4.4.1: APAC Female Infertility Diagnosis and Treatment Market by Treatment: Drugs, Surgery, Intrauterine Insemination, and Assisted Reproductive Technology
    • 4.4.2: APAC Female Infertility Diagnosis and Treatment Market by End Use: Hospitals and Clinics, Homecare, Pathology and Diagnostic Centers, and Others
  • 4.5: ROW Female Infertility Diagnosis and Treatment Market
    • 4.5.1: ROW Female Infertility Diagnosis and Treatment Market by Treatment: Drugs, Surgery, Intrauterine Insemination, and Assisted Reproductive Technology
    • 4.5.2: ROW Female Infertility Diagnosis and Treatment Market by End Use: Hospitals and Clinics, Homecare, Pathology and Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Female Infertility Diagnosis and Treatment Market by Treatment
    • 6.1.2: Growth Opportunities for the Global Female Infertility Diagnosis and Treatment Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Female Infertility Diagnosis and Treatment Market by End Use
    • 6.1.4: Growth Opportunities for the Global Female Infertility Diagnosis and Treatment Market by Region
  • 6.2: Emerging Trends in the Global Female Infertility Diagnosis and Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Female Infertility Diagnosis and Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Female Infertility Diagnosis and Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bayer AG
  • 7.2: Church & Dwight
  • 7.3: Genea
  • 7.4: Pfizer
  • 7.5: Vitrolife Sweden AB
  • 7.6: Esco Group
  • 7.7: Fairhaven Health
  • 7.8: Ferring B.V.